By Filip Karinja The Big Pharma industry is set for a major shakeup as many blockbuster drugs begin to come off patent. Some high revenue generating drugs will soon no longer be covered by their protective patents, meaning cheaper generic drugs can flood the market. AstraZeneca’s blockbuster cholesterol drug Crestor was one of the most prescribed drugs in 2015 …